Invesco Aktie News

Sixteen of the thirty-eight highest-yield, 'safer' S&P 500 dividend stocks are highlighted as ready to buy, with adequate free cash flow supporting payouts. Analyst forecasts suggest top ten S&P 500 dividend 'dogs' could deliver 20.45% to 38.5% net gains by September 2026, with an average gain of 27.35%. Stocks like Amcor, Healthpeak, Conagra, Pfizer, and Verizon offer the best combination of h...

Invesco Ltd. (NYSE:IVZ ) Barclays 23rd Annual Global Financial Services Conference September 9, 2025 7:30 AM EDT Company Participants Andrew Schlossberg - President, CEO & Director Allison Dukes - Senior MD & CFO Conference Call Participants Benjamin Budish - Barclays Bank PLC, Research Division Presentation Benjamin Budish Research Analyst All right.

ATLANTA , Sept. 9, 2025 /PRNewswire/ -- Invesco Ltd.

There were only 22 trading days in July. But that was all the time that the five best-performing S&P 500 stocks that month needed to gain 24% or more.

ATLANTA and LONDON , Aug. 26, 2025 /PRNewswire/ -- Global investment firm Carlyle (NASDAQ: CG) and Invesco (NYSE: IVZ), a leading global asset management firm, announced today an agreement for Carlyle to acquire intelliflo from Invesco. intelliflo is a market leading provider of cloud-based practice management software for independent financial advisors (IFAs) in the UK.

Many high-yield S&P 500 stocks are risky, but 19 'safer' dividend dogs have strong free cash flow to support payouts and are worth considering. Analyst forecasts suggest the top ten S&P 500 dividend dogs could deliver 23% to 40% net gains by August 2026, with moderate risk. A market correction or dividend increases could make all top ten 'safer' dividend dogs attractively priced, maximizing yie...

ATLANTA , Aug. 11, 2025 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ)1 today reported preliminary month-end assets under management (AUM) of $2,024.5 billion, an increase of 1.2% versus previous month-end.

NVIDIA, Microsoft, and Netflix were top contributors, driven by strong earnings, AI leadership, and robust subscriber/ad growth, reinforcing our long-term conviction in these names. UnitedHealth and Apple underperformed due to margin pressures, regulatory uncertainty, and mixed AI sentiment, but we remain confident in their multi-year value propositions. Our short position in QQQ detracted as t...